Diagnamed Holdings Corp.
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It has a collaboration agreement with EIREX for the development and commerc… Read more
Diagnamed Holdings Corp. (DGNMF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.150x
Based on the latest financial reports, Diagnamed Holdings Corp. (DGNMF) has a cash flow conversion efficiency ratio of 0.150x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-67.64K) by net assets ($-450.11K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Diagnamed Holdings Corp. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Diagnamed Holdings Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Diagnamed Holdings Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Diagnamed Holdings Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Damodar Industries Limited
NSE:DAMODARIND
|
0.146x |
|
Kula Gold Ltd
AU:KGD
|
-0.204x |
|
Shuttle Pharmaceuticals Inc
NASDAQ:SHPH
|
-1.884x |
|
Sirona Biochem Corp
PINK:SRBCF
|
0.160x |
|
ARCUS DEVELOPMENT
MU:AJR
|
0.000x |
|
Exemplar REITail Ltd
JSE:EXP
|
0.021x |
|
RENEURON GRP PLC LS-01
F:RQE1
|
N/A |
|
Guardforce AI Co. Limited Warrant
NASDAQ:GFAIW
|
-0.021x |
Annual Cash Flow Conversion Efficiency for Diagnamed Holdings Corp. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Diagnamed Holdings Corp. from 2021 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $-450.11K | $-336.07K | 0.747x | -55.49% |
| 2024-09-30 | $-265.17K | $-444.82K | 1.677x | +137.07% |
| 2023-09-30 | $235.89K | $-1.07 Million | -4.525x | -615.99% |
| 2022-09-30 | $1.25 Million | $-787.58K | -0.632x | -150.29% |
| 2021-09-30 | $2.24 Million | $-565.60K | -0.253x | -- |